Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry

Journal of Infection

Volumn 65, Issue 5, 2012, Pages 453-464

  Steinbach, William J ^a   Marr, Kieren A ^b   Anaissie, Elias J ^c   Azie, Nkechi ^d   Quan, Shun Ping ^d   Meier Kriesche, Herwig Ulf ^d   Apewokin, Senu ^c   Horn, David L ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^d ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^e David Horn LLC   (United States)

Author keywords

Antifungal; Aspergillus; Epidemiology; Invasive aspergillosis; PATH Alliance

Indexed keywords

AMPHOTERICIN B; ECHINOCANDIN; VORICONAZOLE;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANADA; DISEASE REGISTRY; DISEASE SURVEILLANCE; FEMALE; HUMAN; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORBIDITY; MORTALITY; NONHUMAN; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROSPECTIVE STUDY; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROSPECTIVE STUDIES; REGISTRIES;

EID: 84867336299     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.08.003     Document Type: Article

References (33)

1. 3 Aspergillus Study Group. Medicine (Baltimore) 2000, 79:250-260.
2. Herbrecht R., Denning D.W., Patterson T.F., Bennett J.E., Greene R.E., Oestmann J.W., et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002, 347:408-415.
3. Denning D.W., Marinus A., Cohen J., Spence D., Herbrecht R., Pagano L., et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect 1998, 37:173-180.
4. Cornet M., Fleury L., Maslo C., Bernard J.F., Brücker G. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect 2002, 51:288-296.
5. Baddley J.W., Andes D.R., Marr K.A., Kontoyiannis D.P., Alexander B.D., Kauffman C.A., et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010, 50:1559-1567.
6. Segal B.H. Aspergillosis. N Engl J Med 2009, 360:1870-1884.
7. Horn D., Sae-Tia S., Neofytos D. Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry. Diagn Microbiol Infect Dis 2009, 63:384-387.
8. Neofytos D., Horn D., Anaissie E., Steinbach W., Olyaei A., Fishman J., et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009, 48:265-273.
9. Davis J.A., Horn D.L., Marr K.A., Fishman J.A. Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS. Transpl Infect Dis 2009, 11:432-437.
10. Horn D., Neofytos D., Fishman J., Steinbach W., Anaisie E., Marr K.A., et al. Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia. Eur J Clin Microbiol Infect Dis 2007, 26:907-914.
11. Horn D.L., Neofytos D., Anaissie E.J., Fishman J.A., Steinbach W.J., Olyaei A.J., et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009, 48:1695-1703.
12. Horn D.L., Fishman J.A., Steinbach W.J., Anaissie E.J., Marr K.A., Olyaei A.J., et al. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections. Diagn Microbiol Infect Dis 2007, 59:407-414.
13. Klevay M.J., Horn D.L., Neofytos D., Pfaller M.A., Diekema D.J. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection. Diagn Microbiol Infect Dis 2009, 64:152-157.
14. Neofytos D., Fishman J.A., Horn D., Anaissie E., Chang C.H., Olyaei A., et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 2010, 12:220-229.
15. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert F., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14.
16. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
17. Pagano L., Caira M., Candoni A., Offidani M., Fianchi L., Martino B., et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006, 91:1068-1075.
18. Marr K.A., Carter R.A., Crippa F., Wald A., Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:909-917.
19. Kontoyiannis D.P., Marr K.A., Park B.J., Alexander B.D., Anaissie E.J., Walsh T.J., et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010, 50:1091-1100.
20. Burgos A., Zaoutis T.E., Dvorak C.C., Hoffman J.A., Knapp K.M., Nania J.J., et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 2008, 121:e1286-e1294.
21. Zaoutis T.E., Heydon K., Chu J.H., Walsh T.J., Steinbach W.J. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 2006, 117:e711-e716.
22. Pappas P.G., Alexander B.D., Andes D.R., Hadley S., Kauffman C.A., Freifeld A., et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010, 50:1101-1111.
23. Trullas J.C., Cervera C., Benito N., de la Bellacasa J.P., Agustí C., Rovira M., et al. Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients. Transplant Proc 2005, 37:4091-4093.
24. Pagano L., Caira M., Nosari A., Van Lint M.T., Candoni A., Offidani M., et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study - Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007, 45:1161-1170.
25. Singh N., Avery R.K., Munoz P., Pruett T.L., Alexander B., Jacobs R., et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003, 36:46-52.
26. Perfect J.R., Cox G.M., Lee J.Y., Kauffman C.A., de Repentigny L., Chapman S.W., et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001, 33:1824-1833.
27. Lortholary O., Gangneux J.P., Sitbon K., Lebeau B., de Monbrison F., Le Strat Y., et al. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). Clin Microbiol Infect 2011, 17:1882-1889.
28. Hachem R.Y., Kontoyiannis D.P., Boktour M.R., Afif C., Cooksley C., Bodey G.P., et al. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer 2004, 101:1594-1600.
29. Lass-Flörl C., Griff K., Mayr A., Petzer A., Gastl G., Bonatti H., et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 2005, 131:201-207.
30. Fianchi L., Picardi M., Cudillo L., Corvatta L., Mele L., Trapè G., et al. Aspergillus niger infection in patients with haematological diseases: a report of eight cases. Mycoses 2004, 47:163-167.
31. Pagano L., Caira M., Candoni A., Offidani M., Martino B., Specchia G., et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica 2010, 95:644-650.
32. Upton A., Kirby K.A., Carpenter P., Boeckh M., Marr K.A. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007, 44:531-540.
33. Nivoix Y., Velten M., Letscher-Bru V., Moghaddam A., Natarajan-Amé S., Fohrer C., et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008, 47:1176-1184.